Cargando…
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with CO...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666361/ https://www.ncbi.nlm.nih.gov/pubmed/34966651 http://dx.doi.org/10.14218/JCTH.2020.00099 |
_version_ | 1784614191991095296 |
---|---|
author | Kalal, Chetan R. Joshi, Harshad Kumar, Vivek Gopal, Divya Rathod, Darshana Shukla, Ashish Gianchandani, Tarang Bhatt, Chetan |
author_facet | Kalal, Chetan R. Joshi, Harshad Kumar, Vivek Gopal, Divya Rathod, Darshana Shukla, Ashish Gianchandani, Tarang Bhatt, Chetan |
author_sort | Kalal, Chetan R. |
collection | PubMed |
description | BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with COVID-19 from March 2020 to July 2020. Clinical details were retrieved from electronic medical records to obtain clinical characteristics, medical history, laboratory tests, therapeutic intervention, and outcome data. RESULTS: A total of 184 patients with COVID-19 were included (median age: 45.5 years), comprised of 62.5% men. In total, 22 (12.0%) patients had severe infection and 162 (88.0%) had mild to moderate infection. Overall, 95 (51.6%) showed abnormal liver function test (LFT) and 17 (9.2%) showed normal LFT at admission. The median age, hospital stay, and LFT were significantly higher in severe vs. non-severe infection (p<0.001). Out of 12 deaths, the majority were due to severe infection (n=11). Deaths were also due to acute respiratory distress syndrome (n=5), cardiac reasons (n=3), and sepsis with multiorgan failure (n=3). The median age, hospital stay and number of intensive care unit admissions were higher in patients having abnormal LFT compared to normal LFT. Incidence of elevated aspartate aminotransferase (42.8% and 40.4%), alanine transaminase (43.7% and 41.6%), and hypoalbuminemia (71.4% and72.7%) at admission and discharge were more common in severe infection. The mean survival was significantly lower in severe infection compared to those with non-severe disease (17.2 vs. 52.3 days; p<0.001). CONCLUSIONS: Incidence of abnormal liver function was higher in patients with severe COVID-19 and was associated with prolonged hospital stay; mortality was associated with severity of COVID-19. For ruling out the risk of liver injury, it is crucial to vigilantly monitor the liver function parameters in patients with COVID-19 admitted to hospital. |
format | Online Article Text |
id | pubmed-8666361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | XIA & HE Publishing Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86663612021-12-28 Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India Kalal, Chetan R. Joshi, Harshad Kumar, Vivek Gopal, Divya Rathod, Darshana Shukla, Ashish Gianchandani, Tarang Bhatt, Chetan J Clin Transl Hepatol Original Article BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with COVID-19 from March 2020 to July 2020. Clinical details were retrieved from electronic medical records to obtain clinical characteristics, medical history, laboratory tests, therapeutic intervention, and outcome data. RESULTS: A total of 184 patients with COVID-19 were included (median age: 45.5 years), comprised of 62.5% men. In total, 22 (12.0%) patients had severe infection and 162 (88.0%) had mild to moderate infection. Overall, 95 (51.6%) showed abnormal liver function test (LFT) and 17 (9.2%) showed normal LFT at admission. The median age, hospital stay, and LFT were significantly higher in severe vs. non-severe infection (p<0.001). Out of 12 deaths, the majority were due to severe infection (n=11). Deaths were also due to acute respiratory distress syndrome (n=5), cardiac reasons (n=3), and sepsis with multiorgan failure (n=3). The median age, hospital stay and number of intensive care unit admissions were higher in patients having abnormal LFT compared to normal LFT. Incidence of elevated aspartate aminotransferase (42.8% and 40.4%), alanine transaminase (43.7% and 41.6%), and hypoalbuminemia (71.4% and72.7%) at admission and discharge were more common in severe infection. The mean survival was significantly lower in severe infection compared to those with non-severe disease (17.2 vs. 52.3 days; p<0.001). CONCLUSIONS: Incidence of abnormal liver function was higher in patients with severe COVID-19 and was associated with prolonged hospital stay; mortality was associated with severity of COVID-19. For ruling out the risk of liver injury, it is crucial to vigilantly monitor the liver function parameters in patients with COVID-19 admitted to hospital. XIA & HE Publishing Inc. 2021-12-28 2021-05-13 /pmc/articles/PMC8666361/ /pubmed/34966651 http://dx.doi.org/10.14218/JCTH.2020.00099 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kalal, Chetan R. Joshi, Harshad Kumar, Vivek Gopal, Divya Rathod, Darshana Shukla, Ashish Gianchandani, Tarang Bhatt, Chetan Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title | Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title_full | Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title_fullStr | Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title_full_unstemmed | Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title_short | Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India |
title_sort | clinical significance of liver function abnormality in patients with covid-19: a single-center experience from western india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666361/ https://www.ncbi.nlm.nih.gov/pubmed/34966651 http://dx.doi.org/10.14218/JCTH.2020.00099 |
work_keys_str_mv | AT kalalchetanr clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT joshiharshad clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT kumarvivek clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT gopaldivya clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT rathoddarshana clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT shuklaashish clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT gianchandanitarang clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia AT bhattchetan clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia |